Stem cells for Crohn's disease

This trial provides access to an experimental stem cell treatment made from a patient's own fat cells (adipose-derived mesenchymal stem cells) for people with brain injury. The goal is to see if this treatment can help improve recovery from brain injury.

This trial studies whether an “autologous” stem cell transplant (using your own cells) can improve Crohn’s disease that has not responded to standard treatments. It may help people who have ongoing, hard-to-control Crohn’s even after medicines and/or who have complications that make surgery risky.

This early-phase study tests whether a stem cell transplant can improve Crohn’s disease in teens and young adults whose disease is active and not responding to standard medicines. It may help some people who are not doing well despite several prior treatments, but it also involves intensive study procedures and safety checks.

This trial tests whether injecting donated stem cells into complex anal fistulas can help heal them in people with Crohn's disease. You may qualify if you have a fistula that hasn't improved with standard treatments.

This trial tests whether a stem cell transplant from a partially matched family member or unrelated donor can help people with severe, hard-to-treat Crohn disease, especially when it starts early or has a known genetic cause. The transplant aims to replace the immune system to stop the disease from attacking the gut.

This study tests injections of stem cells placed directly into Crohn’s affected tissue. It may help people whose Crohn’s disease lesions have not responded to standard medicines and biologic therapies.